Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mantero

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
Cell and Tissue Research|July 5, 1978
Effects of ACTH and 3',5'-cyclic purine nucleotides on the morphology and metabolism of normal adult human adrenocortical cells in primary tissue cultureU Armato, G G Nussdorfer, G Neri, et al.
Journal of Endocrinological Investigation|February 1, 1990
Atrial natriuretic peptide in Cushing's diseaseG Opocher, S Rocco, G Carpenè, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1986
Opioid modulation of normal and pathological human chromaffin tissueM Mannelli, M Maggi, M L DeFeo, et al.
Journal of Endocrinological Investigation|November 20, 2010
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-upN M Albiger, G Occhi, F Sanguin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronismS Ulick, C K Chan, J R Gill, et al.
Journal of Endocrinological Investigation|July 3, 2010
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-upF Ceccato, G Occhi, N M Albiger, et al.
Pituitary|March 8, 2013
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?M Barbot, N Albiger, F Ceccato, et al.
Klinische Wochenschrift|May 15, 1987
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesisF Fallo, N Sonino, M Boscaro, et al.
Journal of Endocrinological Investigation|May 1, 1989
The pathogenesis of pseudohyperaldosteronism from carbenoxoloneD Armanini, M Scali, M C Zennaro, et al.
Journal of Endocrinological Investigation|September 4, 1999
Natriuretic peptides receptors in human aldosterone-secreting adenomasR Sarzani, G Opocher, M V Paci, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
Cell and Tissue Research|July 5, 1978
Effects of ACTH and 3',5'-cyclic purine nucleotides on the morphology and metabolism of normal adult human adrenocortical cells in primary tissue cultureU Armato, G G Nussdorfer, G Neri, et al.
Journal of Endocrinological Investigation|February 1, 1990
Atrial natriuretic peptide in Cushing's diseaseG Opocher, S Rocco, G Carpenè, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1986
Opioid modulation of normal and pathological human chromaffin tissueM Mannelli, M Maggi, M L DeFeo, et al.
Journal of Endocrinological Investigation|November 20, 2010
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-upN M Albiger, G Occhi, F Sanguin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronismS Ulick, C K Chan, J R Gill, et al.
Journal of Endocrinological Investigation|July 3, 2010
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-upF Ceccato, G Occhi, N M Albiger, et al.
Pituitary|March 8, 2013
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?M Barbot, N Albiger, F Ceccato, et al.
Klinische Wochenschrift|May 15, 1987
Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesisF Fallo, N Sonino, M Boscaro, et al.
Journal of Endocrinological Investigation|May 1, 1989
The pathogenesis of pseudohyperaldosteronism from carbenoxoloneD Armanini, M Scali, M C Zennaro, et al.
Journal of Endocrinological Investigation|September 4, 1999
Natriuretic peptides receptors in human aldosterone-secreting adenomasR Sarzani, G Opocher, M V Paci, et al.
Pageof 26